Literature DB >> 1358824

Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography.

M Linderholm1, A Billström, B Settergren, A Tärnvik.   

Abstract

In a prospective study 19 adult patients with nephropathia epidemica were examined in the acute phase of disease with computed tomography (CT) of the lungs and conventional chest radiography. Infiltrates and/or pleural effusions were seen in ten of 19 patients. In two of the patients, abnormalities were disclosed only by CT. Patients with pathologic radiography findings had a more pronounced inflammatory response, as measured by C-reactive protein and leukocyte count, than did those with normal radiography findings. It is concluded that radiological evidence of pulmonary involvement is a common finding early in the course of nephropathia epidemica. The possibility that the lung may be a site of viral replication merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358824     DOI: 10.1007/bf01710791

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  A Swedish fatal case of nephropathia epidemica.

Authors:  M Linderholm; B Settergren; C Ahlm; L A Burman; S Träff; U Bäcklund; P Juto
Journal:  Scand J Infect Dis       Date:  1991

3.  Nephropathia epidemica: immunohistochemical study of pathogenesis.

Authors:  E J Jokinen; J Lähdevirta; Y Collan
Journal:  Clin Nephrol       Date:  1978-01       Impact factor: 0.975

4.  Nephropathia epidemica in Finland. A clinical histological and epidemiological study.

Authors:  J Lähdevirta
Journal:  Ann Clin Res       Date:  1971

5.  Isolation of the nephropathia epidemica agent in Sweden.

Authors:  B Niklasson; J Le Duc
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

6.  Case of epidemic nephropathy associated with disseminated intravascular coagulation.

Authors:  B Settergren; R Norrby; U Näslund; G Wadell
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

Review 7.  Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome.

Authors:  T M Cosgriff
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

8.  Hemorrhagic fever with renal syndrome: mode of transmission to humans.

Authors:  T F Tsai
Journal:  Lab Anim Sci       Date:  1987-08

9.  Detection of nephropathia epidemica virus RNA in patient samples using a nested primer-based polymerase chain reaction.

Authors:  O Grankvist; P Juto; B Settergren; C Ahlm; L Bjermer; M Linderholm; A Tärnvik; G Wadell
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  16 in total

Review 1.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  [Acute hantavirus infection caused by a genetically newly identified viral strain. Severe and complicated course of hemorrhagic fever with renal syndrome (nephropathia epidemica)].

Authors:  B Lauer; M Wiemer; A Kramer; J Pilaski; P Heering; D Horstkotte; H P Schultheiss; B E Strauer
Journal:  Med Klin (Munich)       Date:  1999-01-15

3.  High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini S A Huhtala; Mikko Hurme; Daniel H Libraty; Simo S Oja; Ilkka H Pörsti; Jaana T Syrjänen; Antti Vaheri; Jukka T Mustonen
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

4.  The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini Sa Huhtala; Mikko Hurme; Antti S Paakkala; Ilkka H Pörsti; Jaana T Syrjänen; Jukka T Mustonen
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

5.  Renal MRI findings and their clinical associations in nephropathia epidemica: analysis of quantitative findings.

Authors:  A Paakkala; P Dastidar; P Ryymin; H Huhtala; J Mustonen
Journal:  Eur Radiol       Date:  2004-06-05       Impact factor: 5.315

6.  A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses.

Authors:  B Hjelle; S Jenison; N Torrez-Martinez; T Yamada; K Nolte; R Zumwalt; K MacInnes; G Myers
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Emergence of hantaviral disease in the southwestern United States.

Authors:  B Hjelle; S Jenison; G Mertz; F Koster; K Foucar
Journal:  West J Med       Date:  1994-11

8.  Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

Authors:  S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

9.  Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus.

Authors:  J Rasmuson; C Andersson; E Norrman; M Haney; M Evander; C Ahlm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-15       Impact factor: 3.267

10.  Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome.

Authors:  Lisa Pettersson; Jonas Klingström; Jonas Hardestam; Ake Lundkvist; Clas Ahlm; Magnus Evander
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.